The Right RIA For You. All content copyrighted © 2019 – onwards by Ambastha Financial LLC.
By Kuldip K. Ambastha (This week’s update is a follow-up to What Caught Our Attention in the Investment World? – Week of October 28-November 1, 2019.) On Wednesday, September 9, 2020, the stock of Tiffany & Co. saw a -6.4% return. Tiffany & Co. (TIF) and LVMH Moët Hennessy (LVMH) (LVMUY) were in the news …
Continue reading “What Caught Our Attention in the Investment World? – Week of September 8-11, 2020”
By Kuldip K. Ambastha The American stock exchanges list a variety of companies from all over the world. Restrictions may be soon rolled out for Chinese (and other non-U.S.) companies listed on American stock exchanges, due to the Holding Foreign Companies Accountable (HFCA) Act already passed unanimously by the U.S. Senate on Wednesday, May 20, …
Continue reading “What Caught Our Attention in the Investment World? – Week of May 18 – 22, 2020”
By Kuldip K. Ambastha and Anil K. Ambastha On Friday, January 3, 2020, Tesla, Inc. (TSLA) delivered a gain of 3.0% closing at an all-time high of $443.01 per share due to positive news. Intra-day, the share price reached as high as $454.00 per share. Tesla beat Wall Street estimates for both car production and …
By Kuldip K. Ambastha and Anil K. Ambastha On October 28, 2019, New York-based Tiffany & Co.’s stock (TIF) jumped 31.6% for a record one-day gain. The stock surged due to the announcement of a potential $14.5 billion (USD) acquisition bid from LVMH Moët Hennessy (LVMH). LVMH is a Paris-based French company headed by the …
By Kuldip K. Ambastha and Anil K. Ambastha On October 22, 2019, Biogen Inc. (BIIB) delivered a 26.1% return for the day. This was the stock’s largest one-day percentage return in 23 years. Its Alzheimer’s drug (aducanumab) had previously been written off as a failure, but now will be getting a second chance at approval …
Continue reading “What Caught Our Attention in the Investment World? – Week of October 21-25, 2019”
By Kuldip K. Ambastha and Anil K. Ambastha Acadia Pharmaceuticals Inc. (ACAD) is a biopharmaceutical company which has Nuplazid (aka: pimavanserin) in its product pipeline. Nuplazid has been used by individuals suffering from Parkinson’s disease-linked psychosis. Acadia has now analyzed Nuplazid in relation to individuals suffering from dementia-related psychosis. Currently, no approved drugs exist in …
Continue reading “What Caught Our Attention in the Investment World? – Week of September 9-13, 2019”
By Anil K. Ambastha and Kuldip K. Ambastha Following its disappointing second-quarter earnings due to deep discounting amid rising inventory levels, concern about the potential impact of China tariffs in the future, and slashed earnings guidance for the rest of the year, shares of a retailer, Macy’s (M), dropped by 13.2% on August 14. Macy’s …
Continue reading “What Caught Our Attention in the Investment World? – Week of August 12-16, 2019”
By Anil K. Ambastha and Kuldip K. Ambastha Following its second-quarter earnings report featuring lower than expected losses, higher than expected revenues, a year-over-year 39% increase of active users to 30.5 million, and bright future guidance, shares of a TV streaming platform operator, Roku (ROKU), rose by 20.9% on August 8. The company has lifted …
Continue reading “What Caught Our Attention in the Investment World? – Week of August 5-9, 2019”
By Anil K. Ambastha and Kuldip K. Ambastha Food industry and restaurant industry stocks generally move in a slow and steady manner. Also, once the initial hype is over shortly after an Initial Public Offering (IPO) of a company’s stock, generally, the IPO shares start to decline and, mostly, an IPO’s shares trade for less …
Continue reading “What Caught Our Attention in the Investment World? – Week of July 22-26, 2019”